Skip to content

Capsule colonoscopy option increases uptake of colorectal cancer screening

Capsule colonoscopy option increases uptake of colorectal cancer screening: a prospective regional study in Germany

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN59303311
Enrollment
2150
Registered
2011-07-28
Start date
2009-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer screening Cancer Colorectal cancer

Interventions

2150 participants receive an invitation letter for colorectal cancer screening by either conventional or capsule endoscopy. The pros and cons of each are briefly described and can be further discussed

Sponsors

Given Imaging Ltd. (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Persons over 55 years of age eligible for screening insured with BKK 24 in the area of Rinteln/Lower Saxonia (Germany) are invited by a letter sent out from BKK 24 medical insurance during 2009 to participate in screening using either capsule or conventional colonoscopy. 2. Interested persons are informed by four gastroenterologists and one of the tests will then be performed at screnees choice

Exclusion criteria

Exclusion criteria: 1. Symptomatic persons 2. Persons having undergone screening colonoscopy

Design outcomes

Primary

MeasureTime frame
Uptake of capsule and conventional endoscopy after invitation (measured whenever patients react to the letters, usually within a few weeks) as compared to spontaneous uptake in the same area in the preceeding years

Secondary

MeasureTime frame
1. Adenoma yield in both groups, namely the capsule group including those participants with subsequent colonoscopy, and the group with capsule colonoscopy only 2. Rate of capsule examinations with sufficient bowel preparation (grading was done on a 4-point scale in accordance with previous studies 3. Adverse events and complications in both arms of the study 4. Patient opinion and acceptability according to the questionnaires Measured during or after (2 weeks) performance of either conventional and/or capsule endoscopy

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026